PENTAMIDINE ISETHIONATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H24N4O2.2C2H6O4S
Molecular Weight	592.683
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OCCS(O)(=O)=O.OCCS(O)(=O)=O.NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1

InChI

InChIKey=YBVNFKZSMZGRAD-UHFFFAOYSA-N

InChI=1S/C19H24N4O2.2C2H6O4S/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23;2*3-1-2-7(4,5)6/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23);2*3H,1-2H2,(H,4,5,6)

HIDE SMILES / InChI

Molecular Formula	C19H24N4O2
Molecular Weight	340.4195
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C2H6O4S
Molecular Weight	126.132
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf
Curator's Comment: description was created based on several sources, including: http://www.drugbank.ca/drugs/DB00738 https://en.wikipedia.org/wiki/Pentamidine

Pentamidine (formulated as a salt, pentamidine diisethionate or dimesilate) is an antimicrobial medication given for prevention and treatment of pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii (formerly known as Pneumocystis carinii), a severe interstitial type of pneumonia often seen in patients with HIV infection. The drug is also the mainstay of treatment for stage I infection with Trypanosoma bruceigambiense (West African trypanosomiasis). Pentamidine is also used as a prophylactic against PCP in patients receiving chemotherapy and in some patients who have undergone organ transplantation, as they also have a depressed immune system as a direct side-effect of the drugs used. The mortality of untreated PCP is very high. Additionally, pentamidine has good clinical activity in treating leishmaniasis, and yeast infections caused by the organism Candida albicans. Pentamidine is also used as a prophylactic antibiotic for children undergoing treatment for leukemia. Studies suggest that the pentamidine isethionate interferes with microbial nuclear metabolism by inhibition of DNA, RNA, phospholipid and protein synthesis. However, the mode of action is not fully understood.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
tRNA (cytosine(38)-C(5))-methyltransferase 6 Target ID: O14717 Gene ID: 1787.0 Gene Symbol: TRDMT1 Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275129/	Binding Agent 1064		204.4 µM [EC50]
DNA 278 Target ID: CHEMBL2366046 Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb#nlm34090-1	Inhibitor 8297

Conditions

Condition	Modality	Targets	Highest Phase	Product
Pneumocystis jiroveci pneumonia (PJP) in high-risk, HIV-infected patients 6 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf	Preventing		Approved 8429	NEBUPENT Approved Use Pentamidine Launch Date 1985

C_max

Value	Dose	Analyte	Population
751 nM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8056699	3.9 mg/kg 1 times / day multiple, intravenous dose: 3.9 mg/kg route of administration: Intravenous experiment type: MULTIPLE co-administered:	PENTAMIDINE blood	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
18.8 ng/mL DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf	4 mg/kg 1 times / day multiple, irrigation dose: 4 mg/kg route of administration: Irrigation experiment type: MULTIPLE co-administered:	PENTAMIDINE unknown	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
612 ng/mL DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf	4 mg/kg single, intravenous dose: 4 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered:	PENTAMIDINE unknown	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
6734 nM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8056699	3.9 mg/kg 1 times / day multiple, intravenous dose: 3.9 mg/kg route of administration: Intravenous experiment type: MULTIPLE co-administered:		PENTAMIDINE blood	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
6.4 h DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf	4 mg/kg single, intravenous dose: 4 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered:		PENTAMIDINE unknown	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN

Doses

Dose	Population	Adverse events
1600 mg single, intravenous Overdose Dose: 1600 mg Route: intravenous Route: single Dose: 1600 mg Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display	unhealthy, 17 n = 1 Health Status: unhealthy Condition: Pneumonia due to Pneumocystis carinii Age Group: 17 Population Size: 1 Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display	Other AEs: Impaired renal function, Hepatic impairment... Other AEs: Impaired renal function Hepatic impairment Hypotension Cardiopulmonary arrest Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display
600 mg 1 times / month multiple, respiratory Highest studied dose Dose: 600 mg, 1 times / month Route: respiratory Route: multiple Dose: 600 mg, 1 times / month Sources: https://pubmed.ncbi.nlm.nih.gov/8750367 Page: p.1167	unhealthy, 37.9 ± 7.5 n = 76 Health Status: unhealthy Condition: Pneumonia due to Pneumocystis carinii Age Group: 37.9 ± 7.5 Sex: M+F Population Size: 76 Sources: https://pubmed.ncbi.nlm.nih.gov/8750367 Page: p.1167	Sources: https://pubmed.ncbi.nlm.nih.gov/8750367 Page: p.1167
300 mg 1 times / month multiple, respiratory Recommended Dose: 300 mg, 1 times / month Route: respiratory Route: multiple Dose: 300 mg, 1 times / month Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Page: p.6	unhealthy Health Status: unhealthy Condition: Pneumonia due to Pneumocystis carinii Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Page: p.6	Disc. AE: Acute pancreatitis... AEs leading to discontinuation/dose reduction: Acute pancreatitis Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Page: p.6
4 mg/kg 1 times / day multiple, intramuscular Recommended Dose: 4 mg/kg, 1 times / day Route: intramuscular Route: multiple Dose: 4 mg/kg, 1 times / day Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display	unhealthy Health Status: unhealthy Condition: Pneumonia due to Pneumocystis carinii Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display	Disc. AE: Hypotension, Hypoglycemia... Other AEs: Extravasation, Injection site ulceration... AEs leading to discontinuation/dose reduction: Hypotension (grade 3-5) Hypoglycemia (grade 5) Acute pancreatitis (grade 5) Cardiac arrhythmias (grade 5) Cardiac arrhythmias (grade 5) Other AEs: Extravasation Injection site ulceration Injection site necrosis Slough injection site Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display
4 mg/kg 1 times / day multiple, intravenous Recommended Dose: 4 mg/kg, 1 times / day Route: intravenous Route: multiple Dose: 4 mg/kg, 1 times / day Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display	unhealthy Health Status: unhealthy Condition: Pneumonia due to Pneumocystis carinii Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display	Disc. AE: Hypotension, Hypoglycemia... Other AEs: Extravasation, Injection site ulceration... AEs leading to discontinuation/dose reduction: Hypotension (grade 3-5) Hypoglycemia (grade 5) Acute pancreatitis (grade 5) Cardiac arrhythmias (grade 5) Cardiac arrhythmias (grade 5) Other AEs: Extravasation Injection site ulceration Injection site necrosis Slough injection site Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8&type=display

AEs

Overview

CYP3A4	CYP2C9	CYP2D6	hERG

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer
Kir4.1 6	OCT1 327 P-gp 1537 MRP transporters 10

Drug as perpetrator

Target	Modality	Activity	Metabolite	Clinical evidence
Kir4.1 6	inhibitor 3277 Sources: https://pubmed.ncbi.nlm.nih.gov/28993158/	yes [IC50 0.097 uM]
BCRP 773	activator 214 Sources: https://pubmed.ncbi.nlm.nih.gov/22200378/	yes

Drug as victim

Target	Modality	Activity
MRP transporters 10	substrate 3367 Sources: https://pubmed.ncbi.nlm.nih.gov/19261919/	yes
OCT1 327	substrate 3367 Sources: https://pubmed.ncbi.nlm.nih.gov/28362799/	yes
P-gp 1537	substrate 3367 Sources: https://pubmed.ncbi.nlm.nih.gov/19261919/	yes

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:45081	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:45081
ChemicalBook	CB4476092	https://www.chemicalbook.com/ChemicalProductProperty_EN_CB4476092
MolPort	MolPort-001-792-506	https://www.molport.com/shop/molecule-link/MolPort-001-792-506
ZINC	ZINC000001530775	http://zinc15.docking.org/substances/ZINC000001530775
eMolecules	1012733	https://www.emolecules.com/cgi-bin/more?vid=1012733

PubMed

Title	Date	PubMed
Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.	1974 Mar	4365115
Acute renal failure after nebulised pentamidine.	1989 Jun 3	2566818
Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine.	1989 Sep	2773964
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.	1990 Apr	2319567
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.	1990 Jun	2393262
Pentamidine-associated nephrotoxicity and hyperkalemia in patients with AIDS.	1991 Nov	1763529
[Infantile visceral leishmaniasis in Morocco. A review of 67 cases managed at the Rabat Hospital for children (1979-1988)].	1991 Sep	1659303
High pentamidine levels associated with hypoglycemia and azotemia in a patient with Pneumocystis carinii pneumonia.	1992 Aug	1424505
Torsade de pointes after inhaled pentamidine.	1992 Nov	1416342
Pentamidine is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 receptors.	1999 Jun 21	10415905
Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice.	2000 Sep	10952565
[Human African trypanosomiasis from Trypanosoma brucei gambiense with inoculation chancre in a French expatriate].	2001	11803822
Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report.	2001 Dec	11806628
Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s.	2001 Jan	11124226
Intravenous pentamidine induced megaloblastic anaemia.	2002 Jan	11801480
Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam.	2002 Nov	12453009
Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia.	2004 Sep 6	15357989
A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.	2005 Feb	15342952
Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin.	2005 Oct	17191940
Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening.	2005 Sep	16131481
Using the zebrafish lateral line to screen for ototoxicity.	2008 Jun	18408970
Synthesis and antiprotozoal activity of pyridyl analogues of pentamidine.	2009 Aug 13	19606902
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.	2011 Jul 14	21599003
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.	2013 Dec	24052561
Synthesis and antiprotozoal activity of dicationic 2,6-diphenylpyrazines and aza-analogues.	2013 Nov 1	24012380
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.	2015 May 18	25811541

Patents

Sample Use Guides

In Vivo Use Guide

The recommended adult dosage is 300 mg once every four weeks administered via the Respirgard® II nebulizer. The dose should be delivered until the nebulizer chamber is empty (approximately 30 to 45 minutes). The flow rate should be 5 to 7 liters per minute from a 40 to 50 pounds per square inch (PSI) air or oxygen source. Alternatively, a 40 to 50 PSI air compressor can be used with flow limited by setting the flowmeter at 5 to 7 liters per minute or by setting the pressure at 22 to 25 PSI. Low pressure (less than 20 PSI) compressors should not be used.

Route of Administration: Irrigation

In Vitro Use Guide

Pentamidine was found to be active against T. whipplei strains both in axenic medium and in cell culture, with minimum inhibitory concentration ranges of 0.125-0.25mg/L.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:17:47 GMT 2023` Edited by `admin` on `Fri Dec 15 15:17:47 GMT 2023`
Record UNII	V2P3K60DA2
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PENTAMIDINE ISETHIONATE

Official Name

English

PENTAMIDINE DIISETIONATE [EP MONOGRAPH]

Common Name

English

NEBUPENT

Brand Name

English

PENTAMIDINE ISETHIONATE [USP MONOGRAPH]

Common Name

English

Pentamidine isethionate [WHO-DD]

Common Name

English

PENTAMIDINE ISETIONATE

Common Name

English

PENTAMIDINE ISETHIONATE [ORANGE BOOK]

Common Name

English

MB 800

Code

English

PENTAMIDINE DIISETIONATE

Common Name

English

PENTAMIDINE BIS(2-HYDROXYETHANESULFONATE)

Common Name

English

PENTAMIDINE ISETIONATE [MART.]

Common Name

English

PENTAMIDINE ISETIONATE [WHO-IP]

Common Name

English

PENTAMIDINE ISETHIONATE [MI]

Common Name

English

NSC-757400

Code

English

RP 2512

Code

English

ETHANESULFONIC ACID, 2-HYDROXY-, COMPD. WITH 4,4'-(1,5-PENTANEDIYLBIS(OXY))BIS (BENZENECARBOXIMIDAMIDE)

Common Name

English

4,4'-(PENTANE-1,5-DIYLBIS(OXY))DIBENZIMIDAMIDE BIS(2-HYDROXYETHANESULPHONATE)

Systematic Name

English

4,4'-(PENTANE-1,5-DIYLBIS(OXY))DIBENZIMIDAMIDE BIS(2-HYDROXYETHANESULFONATE)

Systematic Name

English

PENTAMIDINE ISETIONATE [JAN]

Common Name

English

PENTACARINAT

Brand Name

English

NSC-620107

Code

English

PENTAMIDINE ISETHIONATE [USP-RS]

Common Name

English

OCZ103-OS

Code

English

PENTAMIDINE ISETHIONATE [VANDF]

Common Name

English

PENTAMIDINE ISETHIONATE [USAN]

Common Name

English

PENTAMIDINI ISETIONAS [WHO-IP LATIN]

Common Name

English

PENTAMIDINE DIISETIONATE [EP IMPURITY]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C277